GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Isodiol International Inc (OTCPK:ISOLF) » Definitions » EV-to-EBITDA

Isodiol International (Isodiol International) EV-to-EBITDA : 0.00 (As of May. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Isodiol International EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Isodiol International's enterprise value is $0.00 Mil. Isodiol International's EBITDA for the trailing twelve months (TTM) ended in Dec. 2019 was $-68.87 Mil. Therefore, Isodiol International's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Isodiol International's EV-to-EBITDA or its related term are showing as below:

ISOLF's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.42
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Isodiol International's stock price is $1.0E-5. Isodiol International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2019 was $-1.967. Therefore, Isodiol International's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Isodiol International EV-to-EBITDA Historical Data

The historical data trend for Isodiol International's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isodiol International EV-to-EBITDA Chart

Isodiol International Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EV-to-EBITDA
Get a 7-Day Free Trial -6.08 -1.52 -1.91 -6.92 -0.70

Isodiol International Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.94 -0.70 -0.48 -0.16 -

Competitive Comparison of Isodiol International's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Isodiol International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Isodiol International's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Isodiol International's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Isodiol International's EV-to-EBITDA falls into.



Isodiol International EV-to-EBITDA Calculation

Isodiol International's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/-68.866
=0.00

Isodiol International's current Enterprise Value is $0.00 Mil.
Isodiol International's EBITDA for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-68.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Isodiol International  (OTCPK:ISOLF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Isodiol International's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.0E-5/-1.967
=At Loss

Isodiol International's share price for today is $1.0E-5.
Isodiol International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.967.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Isodiol International EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Isodiol International's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Isodiol International (Isodiol International) Business Description

Traded in Other Exchanges
N/A
Address
200 Granville Street, Suite 2710, Vancouver, BC, CAN, V6C 1S4
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.

Isodiol International (Isodiol International) Headlines

From GuruFocus